Simplex Trading, LLC Supernus Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$22.72 - $29.68 $53,210 - $69,510	2,342 Added 1672.86%	2,482 $71,000
Q3 2023 Nov 01, 2023	BUY	$27.57 - $32.91 $3,859 - $4,607	140 New	140 $3,000
Q1 2022 May 02, 2022	SELL	$28.51 - $32.9 $11,888 - $13,719	-417 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$26.37 - $34.22 $170,191 - $220,855	-6,454 Reduced 93.93%	417 $12,000
Q3 2021 Oct 28, 2021	SELL	$23.54 - $31.39 $14,359 - $19,147	-610 Reduced 8.15%	6,871 $215,000
Q2 2021 Aug 12, 2021	SELL	$26.72 - $33.19 $4,649 - $5,775	-174 Reduced 2.27%	7,481 $230,000
Q1 2021 Apr 26, 2021	BUY	$24.15 - $31.45 $184,868 - $240,749	7,655 New	7,655 $0
Q4 2020 Feb 02, 2021	SELL	$17.7 - $25.81 $32,621 - $47,567	-1,843 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$20.2 - $25.05 $402,626 - $499,296	-19,932 Reduced 91.54%	1,843 $38,000
Q2 2020 Jul 13, 2020	SELL	$17.09 - $24.89 $182,008 - $265,078	-10,650 Reduced 32.85%	21,775 $517,000
Q1 2020 Apr 29, 2020	SELL	$14.45 - $24.69 $104,950 - $179,323	-7,263 Reduced 18.3%	32,425 $583,000
Q4 2019 Feb 05, 2020	BUY	$19.93 - $29.13 $381,519 - $557,635	19,143 Added 93.18%	39,688 $941,000
Q3 2019 Oct 15, 2019	BUY	$25.47 - $33.37 $348,404 - $456,468	13,679 Added 199.23%	20,545 $564,000
Q2 2019 Jul 26, 2019	BUY	$29.96 - $38.87 $205,705 - $266,881	6,866 New	6,866 $227,000
Q1 2019 Apr 18, 2019	SELL	$32.77 - $41.99 $805,584 - $1.03 Million	-24,583 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$30.84 - $49.51 $603,754 - $969,257	19,577 Added 391.07%	24,583 $816,000
Q3 2018 Oct 23, 2018	SELL	$42.7 - $56.55 $4,526 - $5,994	-106 Reduced 2.07%	5,006 $252,000
Q2 2018 Jul 30, 2018	BUY	$44.1 - $59.85 $72,235 - $98,034	1,638 Added 47.15%	5,112 $305,000
Q1 2018 Apr 26, 2018	SELL	$37.15 - $46.9 $103,165 - $130,241	-2,777 Reduced 44.42%	3,474 $159,000
Q4 2017 Jan 10, 2018	SELL	$36.4 - $42.6 $68,759 - $80,471	-1,889 Reduced 23.21%	6,251 $249,000
Q3 2017 Oct 25, 2017	BUY	$36.75 - $49.65 $299,145 - $404,151	8,140	8,140 $325,000

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$376 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$222 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$185 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$104 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$95.3 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account